Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 24.72% is 50% below its 5-year average of 49.91%, near the low end of its 5-year range (6.32%–89.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 41.59% below its 12-month average of 42.33%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 24.72%.
DEBT TO ASSETS RATIO
24.72%
DEBT TO ASSETS RATIO AVG TTM
42.33%
DEBT TO ASSETS RATIO AVG 3Y
55.77%
DEBT TO ASSETS RATIO AVG 5Y
49.91%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-41.59%
CURRENT VS 3Y AVG
-55.67%
CURRENT VS 5Y AVG
-50.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 660 covered companies
CURRENT VS SECTOR MEDIAN
+24624.51%
vs the sector median at left
Elutia Inc
Market Cap
$35.52M
Debt to Assets Ratio
24.72%
TTM Avg
42.33%
3Y Avg
55.77%
5Y Avg
49.91%
Market Cap
$34.89M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.25M
Debt to Assets Ratio
0.45%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$34.33M
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$34.18M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.79M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$37.57M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elutia Inc (ELUT) | $35.52M | 24.72% | 42.33% | 55.77% | 49.91% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.89M | 0.00% | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.25M | 0.45% | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $34.33M | 0.41% | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $36.48M | 0.14% | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.18M | 0.00% | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.79M | 0.05% | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $33.25M | 0.00% | N/A | N/A | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $37.57M | 0.00% | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $32.76M | 1.40% | N/A | N/A | N/A |
Debt/Assets
24.7%
Debt/Equity
0.69
Current Ratio
1.77
Interest Coverage
47.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 24.72% |
| 2026-03-31 | 7.64% |
| 2025-12-31 | 6.32% |
| 2025-09-30 | 89.52% |
| 2025-06-30 | 83.43% |
| 2025-03-31 | 63.66% |
| 2024-12-31 | 68.47% |
| 2024-09-30 | 47.79% |
| 2024-06-30 | 54.43% |
| 2024-03-31 | 62.86% |
| 2023-12-31 | 55.15% |
| 2023-09-30 | 47.04% |
| 2023-06-30 | 50.18% |
| 2023-03-31 | 42.90% |
| 2022-12-31 | 36.97% |
| 2022-09-30 | 69.50% |
| 2022-06-30 | 40.90% |
| 2022-03-31 | 75.31% |
| 2021-12-31 | 34.59% |
| 2021-09-30 | 36.83% |
